Inflammation, lipids, and free radicals: Lessons learned from the atherogenic process

Seminars in Reproductive Endocrinology

Volumn 16, Issue 4, 1998, Pages 249-261

  Rosenfeld, M E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apoptosis; Atherosclerosis; Gene expression; Glutathione; Oxidative stress; Proliferation

Indexed keywords

CHOLESTEROL; FREE RADICAL; GLUTATHIONE; LIPID; LIPOXYGENASE; MYELOPEROXIDASE; NITRIC OXIDE; PEROXYNITRITE; PROSTAGLANDIN SYNTHASE; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; CELL DEATH; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GLUTATHIONE METABOLISM; HUMAN; INFLAMMATION; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032426602     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016285     Document Type: Review

References (173)

1. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. Circulation 1994;89:2462-2478
2. Stary HC, Chandler AB, Glagov S, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:1512-1531
3. Gown AM, Tsukada T, Ross R. Human atherosclerosis II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. AM J Pathol 1986;125:191-207
4. Roessner A, Herrera A, Honing HJ. Identification of macrophages and smooth muscle cells with monoclonal antibodies in the human atherosclerotic plaque. Virchows Arch A 1987;412:169-174
5. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-809
6. Hamilton JA, Veis N, Bordun AM, et al. Activation and proliferation signals in murine macrophages: Relationships among c-fos and c-myc expression, phosphinositide hydrolysis, Superoxide formation, and DNA synthesis. J Cell Physiol 1989;141:618-626
7. Ku G, Thomas CE, Akeson AL, Jackson RL. Induction of interleukin-1-beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadeca-dienoic acid. J Biol Chem 1992;267:14183-14188
8. Brand K, Banka CL, Mackman N, et al. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Aterioscler Thromb 1994;14:790-797
9. Shi MM, Godleski JJ, Paulaiski JD. Regulation of macrophage inflammatory protein-1αmRNA by oxidative stress. J Biol Chem 1996;2715878-5883
10. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 1990;186:1-85
11. Fuchs D, Gruber A, Uberall F, Wachter H. Oxidative stress and apoptosis. Immunol Today 1994;15:496
12. Guyton JR, Klemp KF. Development of the atherosclerotic core region. Chemical and ultrastructural analysis of microdissected atheroscleroticlesions from human aorta. Arterioscler Thromb 1994;14:1305-1314
13. London CL, Davies MJ, Born GV, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 1991;87:87-90
14. Bjorkerud S, Bjorkerud B. Apoptosis is abundant inhuman atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of greul and plaque instability. Am J Pathol 1996;149:367-380
15. Davies MJ. Anatomic features in victims of sudden coronary death. Coronary artery patholgy. Circulation 1992;85:I19-I24
16. Falk E. Why do plaques rupture? Circulation 1992;86:(6 Suppl) 111:30-42
17. Kinscherf R, Deigner H-P, Usinger C, et al. Induction of mitochondrial manganese Superoxide dismutase in macrophages by oxidized LDL: Its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J 1997;11:1317-1328
18. Bilzer M, Lauterburg BH. Glutathione metabolism in activated neutrophils: Stimulation of glutathione synthesis and consumption of glutathione by reactive oxygen species. Eur J Clin Invest 1991;21:316-322
19. Utley WS, Mehendale HM. Evidence for stimulated glutathione synthesis by phenobarbital pretreatment during an oxidative challenge in isolated hepatocytes. J Biochem Toxicol 1991;6:101-113
20. Woods JS, Ellis ME. Up-regulation of glutathione synthesis in rat kidney by methyl mercury. Relationship to mercury-induced oxidative stress. Biochem Pharmacol 1995;50:1719-1724
21. Powis G, Briehl M, Oblong J. Redox signalling and the control of cell growth and death. Pharmacol Ther 1995;68:149-173
22. Reed DJ. Review of the current status of calcium and thiols in cellular injury. Chem Res Toxicol 1990;3:495-502
23. Reed DJ. Regulation of reductive processes by glutathione. Biochem Pharmacol 1986;35:7-13
24. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol 1989;257:L163-L173
25. Navab M, Berliner JA, Watson AD, et al. The yin and yang of oxidation in the development of the fatty streak. A re-view based on the 1994 George Lyman Duff Memorial Lecture. Arteriscler Thromb Vasc Biol 1996:16:1-12
26. Rosenfeld ME, Khoo JC, Miller E, et al. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of LDL, and contain oxidation specific lipid-protein adducts. J Clin Invest 1991;87:90-99
27. Pratico D, luliano L, Mauriello A, et al. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest 1997;100:2028-2034
28. Hulten LM, Lindmark H, Diczfalusy U, et al. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J Clin Invest 1996:97:461-468
29. Breuer O, Dzeletovic S, Lund E, Diczfalusy U. The oxysterols cholest-5-ene-3β,4α-diol, cholest-5-ene-3β,4β-diol and cholestane-3β,5α,6α-triol are formed during in vitro oxidation of low density lipoprotein, and are present in human atherosclerotic plaques. Biochim Biophys Acta 1996;1302:145-152
30. Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 1994;77:53-62
31. Chisolm GM, Ma G, Irwin KC, et al. 7-beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc Natl Acad Sci USA 1994;91:11452-11456
32. Coffey MD, Cole RA, Colles SM, Chisolm GM. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals. J Clin Invest 1995;96:1866-1873
33. Gelissen IC, Brown AJ, Mander EL, et al. Sterol efflux is impaired from macrophages foam cells selectively enriched with 7-ketocholesterol. J Biol Chem 19XX;271:17852-17860
34. Darley-Usmar VM, Severn A, O'Leary VJ, Rogers M. Treatment of macrophages with oxidized low-density lipoprotein increases their intracellular glutathione content. Biochem J 1991;278:429-434
35. Sato H, Takenaka Y, Fujiwara K, et al. Increases in cystine transport activity and glutathione level in mouse peritoneal macrophages exposed to oxidized low-density lipoprotein. Biochem Biophys Res Commun 1993;215:154-159
36. Slim RM, Toborek M, Watkins BA, et al. Susceptibility to hepatic oxidative stress in rabbits fed different animal and plant fats. J Am Col Nutr 1996;15:289-294
37. Schoneich C, Dillinger U, von Bruchhausen F, Asmus K-D. Oxidation of polyunsaturated fatty acids and lipids through thiyl and sulfonyl radicals: Reaction kinetics, and influence of oxygen and structure of thiyl radicals. Arch Biochem Biophys 1992;292:456-167
38. Heinecke JW, Kawamura M, Suzuki L, Chait A. Oxidation of low density lipoprotein by thiols: Superoxide dependent and independent mechanisms. J Lipid Res 1993;34:2051-2061
39. Hirano K, Ogihara T, Miki M, et al. Homocysteine induces iron-catalyzed lipid peroxidation of low density lipoprotein that is prevented by alpha-tocopherol. Free Radic Res 1994;21:267-276
40. Gotoh N, Graham A, Nikl E, Darley-Usmar VM. Inhibition of glutathione synthesis increases the toxicity of oxidized low-density lipoprotein to human monocytes and macrophages. Biochem J 1993;296:151-154
41. Rosenblat M, Aviram M. Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LFL: In vitro and in vivo studies. Free Rad Biol Med 1997;24:305-317
42. Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandez-Checa JC. Direct effect of ceramide on mitochondrial electron transport chain leads to generation of reactive oxygen species: Role of mitochondrial glutathione. J Biol Chem 1997;272:11369-11377
43. Goossens V, Grooten J, Fiers W. The oxidative metabolism of glutamine: A modulator of reactive oxygen intermediate-mediated cytotoxicity of tumor necrosis factor in L929 fibrosarcoma cells. J Biol Chem 1996;271:192-196
44. De Vries HE, Ronken E, Reinders JH, et al. Acute effects of oxidized low density lipoprotein on metabolic responses in macrophages. FASEB J 1998;12:111-118
45. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: Implications for atherosclerotic plaque stability. J Clin Invest 1996;98:2572-2579
46. Aviram M, Rosenblat M, Etzioni A, Levy R. Activation of NADFH oxidase required for macrophage-mediated oxidation of low-density lipoprotein. Metabolism 1996;45:1069-1079
47. Kimura H, Minakami H, Kimura S, et al. Release of superoxide radicals by mouse macrophages stimulated by oxidative modification of glycated low density lipoproteins. Atherosclerosis 1995;118:1-8
48. Chao TC, Van Alten PJ, Walter RJ. Steroid sex hormones amd macrophage function: Modulation of reactive oxygen intermediates and nitrite release. Am J Reprod Immunol 1994;32:43-52
49. Daugherty A, Dunn JL, Rateri DL, et al. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994;94:437-444
50. Jacob JS, Cistola DP, Hsu FF, et al. Human phagocytes employ the myeloperoxidase-hydrogen peroxide system to synthesize dityrosine, trityrosine, pulcherosine, and isodityrosine by a tyrosyl radical-dependent pathway. J Biol Chem 1996;271:19950-19956
51. Hazell LJ, Arnold L, Flowers D. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 1996;97:1535-1544
52. Pichorner H, Metodiewa D, Winterbourn CC. Generation of Superoxide and tyrosine peroxide as a result of tyrosyl radical scavenging by glutathione. Arch Biochem Biophys 1995;323:429-437
53. Ylä-Herttuala S, Rosenfeld ME, Parthasarathy S, et al. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci USA 1990;87:6959-6963
54. Ylä-Herttuala S, Rosenfeld ME, Parthasarathy S. Gene expression in macrophage-rich human atherosclerotic lesions: 15-lipoxygenase and acetyl-LDL receptor mRNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 1991;87:1146-1152
55. Benz DJ, Mol M, Ezaki M. Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase. J Biol Chem 1995;270:5191-5197
56. Belkner J, Slender H, Kuhn H. 15-lipoxygenase preferentially oxygenates a subfraction of human low density lipoprotein. In: Honn et al. eds. Eicosinoids and Other Bioactive Lipids in Cancer Inflammation and Radiation Injury. New York: Plenum Press; 1997:465-469
57. Schnurr K, Belkner J, Ursini F, et al. The selenoenzyme phospholipid hydroperoxide glutathione peroxidase controls the activity of the 15-lipoxygenase with complex substrates and preserves the specificity if the oxygenation products. J Biol Chem 1997;271:4653-4658
58. Shen J, Herderick E, Cornhill JF. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 1996;98:2201-2208
59. Luoma JS, Stralin P, Marklund SL, et al. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: Colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol 1998;18:157-167
60. Denlinger LC, Fisette PL, Garis KA, et al. Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem 1996;271:337-342
61. Jessup W. Oxidized lipoproteins and nitric oxide. Curr Opin Lipidol 1996;7:274-280
62. Marcinkiewicz J, Grabowska A, Chain B. Nitrix oxide upregulates the release of inflammatory mediators by mouse macrophages. Eur J Immunol 1995;25:947-951
63. Rubbo H, Parthasarathy S, Barnes S, et al. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: Termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch Biochem Biophys 1995;324:15-25
64. Leeuwenburgh C, Hardy MM, Hazen SL, et al. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 1997;272:1433-1436
65. Loscalzo J. The oxidant stress of hyperhomocysteinemia. Editorial. J Clin Invest 1996;98:5-7
66. Kalyanaraman B. Thiyl radicals in biological systems: Significant or trivial? Biochem Soc Symp 1995;61:55-63
67. Munday R. Toxicity of thiols and disulphides: Involvement of free radical species. Free Rad Biol Med 1989;7:659-673
68. Sies H, Sharov VS, Klotz LO, Briviba K. Glutathione peroxidase protects against peroxynitritie-mediated oxidations: A new function for selenoproteins as peroxynitrite reductase. J Biol Chem 1997;272:27812-27817
69. Del Corso A, Cappiello M, Mura U. Thiol dependent oxidation of enzymes: The last chance against oxidative stress. Int J Biochem 1994;26:745-750
70. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986;77:1370-1376
71. Rosenfeld ME, Tsukada T, Chait A, et al. Fatty streak expansion and maturation in the WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1987;7:24-34
72. Miller YI, Altamentova SM, Shaklai N. Oxidation of low-density lipoproein by hemoglobin stems from a heme-initiated globin radical: Antioxidant role of haptoglobin. Biochemistry 1997;36:12189-12198
73. Nathan CF. Secretory products of macrophages. J Clin Invest 1987;79:319-326
74. Ehrenwald E, Fox PL. Role of endogenous ceruloplasmin in low desity lipoprotein oxidation byhuman U937 monocytic cells. J Clin Invest 1996;97:884-890
75. Swain JA, Darley-Usmar V, Gutteridge JMC. Peroxynitrite releases copper from caeruloplasmin: Implications for atherosclerosis. FEBS Lett 1994;342:49-52
76. Lamb DJ, Mitchinson MJ, Leake DS. Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages. FEBS Lett 1995;374:12-16
77. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-720
78. Baeuerle PA, Rupee RA, Pahl HL. Reactive oxygen intermediates as second messengers of a gneral pathogen response. Pathol Biol Paris 1996;44:29-35
79. Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 1996;97:1715-1722
80. Kaul N, Gopalakrishna R, Gundimeda U, Choi J, Forman HJ. Role of protein kinase C in basal and hydrogen peroxide-stimulated NF-kappa B activation in the murine macrophage J774A.1 cell line. Arch Biochem Biophys 1998;350:79-86
81. Ollivier V, Parry GCN, Cobb RR, de Prost D, Mackman N. Elevated cyclic AMP inhibits NF-kB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 1996;271:20828-20835
82. Hishikawa K, Oemar BS, Yang Z, Luscher TF. Pulsatile stretch stimulates Superoxide production and activates nuclear factor-kappa B in human coronary smooth muscle. Circ Res 1997;81:797-803
83. Rao GN, Glasgow WC, Eling TE, Runge MS. Role of hydroperoxyeicosatetraenoic acids in oxidative stress-induced activating protein 1 (AP-1) activity. J Biol Chem 1996;271:27760-27764
84. Maziere C, Auclair M, Djavaheri-Mergny M, Packer L, Maziere JC. Oxidized low density lipoprotein induces activation of the transcription factor NFkB in fibroblasts, endothelial and smooth muscle cells. Biochem Molec Biol Int 1996;39:1201-1207
85. Ohlsson BG, Englund MCO, Karlsson AK, et al. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kB to DNA and the subsequent expression of tumor necrosis factor-aand interleukin-1βin macrophages. J Clin Invest 1996;98:78-89
86. Chatterjee S, Bhunia AK, Snowden A, Han H. Oxidized low density lipoproteins stimulate galacosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells. Glycobiol 1997;7:703-710
87. Wilmer WA, Tan LC, Dickerson JA, Darme M, Rovin BH. Interleukin-1βinduction of mitogen-activated protein kinases in human mesangial cells. Role of oxidation. J Biol Chem 1997;272:10877-10881
88. Gonz'alez-Rubio M, Voit S, Rodr'iguez-Puyol D, Weber M, Marx M. Oxidative stress induces tyrosine phosphorylation of PDGF alpha and beta-receptors and pp60c-src in mesangial cells. Kidney Int 1996;50:164-173
89. Chen Q, Olashaw N, Wu J. Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway. J Biol Chem 1995;270:28499-28502
90. Brumell JH, Burkhardt AL, Bolen JB, Grinstein S. Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils. J Biol Chem 1996;271:1455-1461
91. Lander HM, Jacovina AT, Davis RJ, Tauras JM. Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J Biol Chem 1996;271:19705-19709
92. +2- ATPase. J Biol Chem 1996;271:29205-29210
93. Marui N, Offermann MK, Swerlick R, et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expresion are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993;92:1866-1874
94. Khan BV, Parthasarathy SS, Alexander RW, Medford RM. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 1995;95:1262-1270
95. Ahmad M, Marui N, Alexander RW, Medford RM. Cell type-specific transactivation of the VCAM-1 promoter through an NF-kappa B enhancer motif. J Biol Chem 1995;270:8976-8983
96. Ahmad M, Theofanidis P, Medford RM. Role of activating protein-1 in the regulation of vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha. J Biol Chem 1998;273:4616-4621
97. Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM. Nitric oxide regulates vascular cell adhesion molecule-1 gene expression and redox-sensitive transcriptional vents in human vascular endothelial cells. Proc Natl Acad Sci USA 1996;93:9114-9119
98. Yamaguchi M, Sato H, Bannai S. Induction of stress proteins in mouse peritoneal macrophages by oxidized low-density lipoprotein. Biochem Biophys Res Commun 1993;193:1198-1201
99. Camhi SL, Alam J, Wiegand GW, Chin BY, Choi AM. Transcriptional activation of the HO-1 gene by lipopolysaccharide is mediated by 5′distal enhancers: Role of reactive oxygen intermediates and AP-1. Am J Respir Cell Molec Biol 1998;18:226-234
100. Forest! R, Clark JE, Green CJ, Motterlini R. Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. Involvement of Superoxide and peroxynitrite anions. J Biol Chem 1997;272:18411-18417
101. VanOtteren GM, Standiford TJ, Kunkel SL, Danforth JM, Strieter RM. Alterations of ambient oxygen tension modulate the expression of tumor necrosis factor and macrophage inflammatory protein-1 alpha from murine alveolar macrophages. Am J Respir Cell Molec Biol 1995;13:399-409
102. Martin T, Cardarclli PM, Parry GC, Felts KA, Cobb RR. Cytokine induction of monocyte chemoatractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol 1997;27:1091-1097
103. Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R. Platelet-derived growth factor-stimulated Superoxide anion production modulates activation of transcription factor NF-kappa B and expression of monocyte chemoattractant protein-1 in human aortic smooth muscle cells. Circulation 1997;96:2361-2367
104. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappa B sites and NF-kappa B/Rel subunit specificity. J Biol Chem 1997;272:31092-31099
105. Gushing SD, Berliner JA, Valente AJ, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990;87:5134-5138
106. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, et al. Expression of monocyte chemotactic protein in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991;88:5252-5256
107. Hamilton TA, Ma GP, Chisolm GM. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages. J Immunol 1990;14:2343-2350
108. Girona J, LaVille AE, Heras M, Olive S, Masana L. Oxidized lipoprotens including HDL and their lipid peroxidation products inhibit TNF-asecretion by THP-1 human macrophages. Free Rad Biol Med 1997;23:658-667
109. Fong LG, Fong TA, Cooper AD. Inhibition of lipopolysaccharide-induced interleukin-1 beta mRNA expression in mouse macropahges by oxidized low density lipoprotein. J Lipid Res 1991;32:1899-1910
110. Lipton BA, Parthasarathy S, Ord VA, et al. Components of the protein fraction of oxidized low-density lipoprotein stimulates interleukin-laproduction by rabbit arterial macrophage-derived foam cells. J Lipid Res 1995;36:2232-2242
111. Mendez C, Garcia I, Maier RV. Oxidants augment endotoxin-induced activation of alveolar macrophages. Shock 1996;6:157-163
112. Wang S, Yan L, Wesley RA, Danner RL. Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP. J Biol Chem 1997;272:5959-5965
113. Ruef J, Hu ZY, Yin LY, et al. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res 1997;81:24-33
114. Leonarduzi G, Scavazza A, Biasi F, et al. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beat-1 expression in the macrophage lineage: A link between oxidative injury and fibrosclerosis. FASEB J 1997;11:851-857
115. Renier G, Desfaits AC, Lambert A, Mikhail R. Role of oxidant injury on macrophage lipoprotein lipase (LPL) production and sensitivity to LPL. J Lipid Res 1996;37:799-809
116. Cader AA, Steinberg FM, Mazone T, Chait A. Mechanisms of enhanced macrophage apo E secretion by oxidized LDL. J Lipid Res 1997;38:981-991
117. Semeraro N, Biondi A, Lorenzet R, et al. Direct induction of tissue factor synthesis by endotoxin in human macropahges from diverse anatomical sites. Immunology 1983;50:529-535
118. Schwartz BS, Levy GA, Curtiss LK, Fair DS, Edgington TS. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: Two procoagulant activities are produced by peripheral blood mononuclear cells. J Clin Invest 1981;67:1650-1658
119. Wilcox JN, Smith KM, Schwartz M, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989;86:2839-2843
120. Kato K, Elsayed YA, Namoto M, Nakagawa K, Sueishi K. Enhanced expression of tissue factor activity in the atherosclerotic aoratas of cholesterol-fed rabbits. Thromb Res 1996;82:335-347
121. Schuff-Werner P, Claus G, Armstrong VW, Kostering H, Seidel D. Enhanced procoagulatory activity (PCA) of human monocytes/macropahges after in vitro Stimulation with chemically modified LDL. Atherosclerosis 1989;78:109-112
122. Weis JR, Pitas RE, Wilson BD, Rodgers GM. Oxidized low-density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation. FASEB J 1991;5:2459-2465
123. Drake TA, Hannani K, Fei HH, Lavi S, Berliner JA. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol 1991;138:601-607
124. Lewis JC, Bennett-Cain AL, DeMars CS, et al. Procoagulant activity after exposure of monocyte-derived macropahges to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface. Am J Pathol 1995;147:1029-1040
125. Parry GC, Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-rel-p65 heterodimers. J Biol Chem 1994;269:20823-20825
126. Durand P, Prost M, Blanche D. Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis 1996;121:231-243
127. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990;87:4600-4604
128. Rosenfeld ME, Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1990;10:680-687
129. Fischer-Dzoga K, Wissler RW. Stimulation of proliferation in stationary primary cultures of monkey aortic smooth muscle cells. Part 2. Effect of varying concentrations of hyperlipemic serum and low density lipoproteins of varying dietary fat origins. Atheroscleosis 1976;24:515-525
130. Agustyn JM, Fritz KE, Daoud AS, Jarmolych J. Effect of lipoprotein on in vitro synthesis of DNA in aortic tissue. Atherosclerosis 1977;27:179-188
131. Libby P, Miao P, Ordovas JM, Schaefer EJ. Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells. J Cell Physiol 1985;124:1-8
132. Chatterjee S. Role of oxidized humanplasma low density lipoproteins in atheroscleosis: Effects on smooth muscle cell proliferation. Mol Cell Biochem 1992;111:143-147
133. Lafont AM, Chai YC, Comhill JF, et al. Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J Clin Invest 1995;95:1018-1025
134. Yui S, Sasaki T, Miyazaki A, Horiuchi S, Yamazaki M. Induction of murine macrophage growth bymodified LDLs. Arterioscler Thromb 1993;13:331-337
135. Aug'e N, Pieraggi MT, Thiers JC, Negre-Salvayre A, Salvayre R. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J 1995;309:1015-1020
136. Sakai M, Miyazaki A, Hakamata H, et al. Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 1996;16:600-605
137. Sakai M, Miyazaki A, Hakamata H, et al. The scavenger receptor serves as a route for intermnalizsation of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage proliferation. J Biol Chem 1996;271:27346-27352
138. Chai YC, Howe PH, DiCorleto PE, Chisolm GM. Oxidized low density lipoprotein and lysophosphatidylcholine stimlate cell cycle entry in vascular smooth muscle cells. J Biol Chem 1996;271:17791-17797
139. Stiko A, Regnstrom J, Shah PK, Cercek B, Nilsson J. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoproteinactivation of smooth muscle cells DNA synthesis. Artqrioscler Thromb Vasc Biol 1996;16:194-200
140. Ananyeva NM, Tjurmin AV, Berliner JA, et al., Oxidized LDL mediates the release of fibroblast growth factor-1. Arterioscler Thromb Vasc Biol 1997;17:445-453
141. Natarajan V, Scribner WM, Hart CM, Parthasarathy S. Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: A possible role in cell proliferation and atherogenesis. J Lipid Res 1995;36:2005-2016
142. Aug'e N, Andrieu N, Negre-Salvayre A, et al., The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J Biol Chem 1996;271:19251-19255
143. Matsumura T, Sakai M, Kobori S, et al. Two intyracellular signaling pathways for activation of protein kinase C are involved in oxidized low-density lipoprotein-induced macrophage growth. Arterioscler Thromb Vasc Biol 1997;17:3013-3020
144. Martens JS, Reiner NE, Herrera-Velit P, Steinbrecher UP. Phosphatidylinositol 3-kinae is involved in the induction of macrophage growth by oxidized low density lipoproein. J Biol Chem 1998;273:4915-4920
145. Roberts CP, Parthasarathy S, Gulati R, Horowitz I, Murphy AA. Effect of RU-486 and related compounds on the proliferation of cultured macrophages. Am J Reprod Immunol 1995;34:248-256
146. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993;69:377-381
147. Geng YJ, Libby P. Eviddence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 1995;147:251-266
148. Han DK, Haudenschild CC, Hong MK, et al. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995;147:267-277
149. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995;91:2703-2711
150. Slater AF, Stefan C, Nobel I, van den Dobbelsteen DJ, Orrenius S. Signalling mechanisms and oxidative stress in apoptosis. Toxicol Lett 1995;82-83:149-153
151. Payne CM, Bernstein C, Bernstein H. Apoptosis overview emphasizing the role of oxidative stress, DNA damage, and signal transduction pathways. Leuk Lymphoma 1995;19:43-93
152. Clutton S. The importance of oxidative stress in apoptosis. Br Med Bull 1997;53:662-668
153. Ghibelli L, Fanelli C, Rotilio G, et al. Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J 1998;12:479-486
154. Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol 1996;16:19-27
155. Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:2200-2208
156. Clement MV, Stamenkovic I. Supoeroxide anion is a natural inhibitor of FAS-mediated cell death. EMBO J 1996;15:216-225
157. Hampton MB, Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis. FEBS Lett 1997;414:552-556
158. Kasahara Y, Iwai K, Yachie A, et al. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/Apo-l)-mediated apoptosis of neutrophils. Blood 1997;89:1748-1753
159. Leszczynski D, Zhao Y, Luokkamaki M, Foegh ML. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. Am J Pathol 1994;145:1265-1270
160. Hessler JR, Robertson AL, Jr, Chisolm GM-3d. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979;32:213-229
161. Henriksen T, Evensen SA, Carlander B. Injury to human endothelial cells in culture induced by low density lipoproteins. Scand J Clin Invest 1979;39:361-368
162. Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 1983;24:1070-1076
163. Sevanian A, Hodis HN, Hwang J, McLeod LL, Perterson H. Characterizationof endothelial cell injury by cholesterol oxidation products found in oxidized LDL. J Lipid Res 1995;36:1971-1986
164. Reid VC, Mitchinson MJ. Toxicity of oxidized low density lipoprotein towars mouse peritoneal macrophages. Atherosclerosis 1993;98:17-24
165. Reid VC, Hardwick SJ, Mitchinson MJ. Fragmentation of DNA in P388D1
166. Yuan XM, Li W, Olsson AG, Brunk UT. The toxicity to macrophages of oxidized low-density lipoprotein is medi-ated through lysosomal damage. Atherosclerosis 1997;133:153-161
167. Muller K, Hardwick SJ, Marchant CE, et al. Cytotoxic and chemotactic potencies of several aldehydic components of oxidized low density lipoprotein for human monocyte-macropahges. FEBS Lett 1996;388:165-168
168. Li L, Hamilton RF, Jr, Kirichenko A, Hoian A. 4-Hydroxynonenal-induced cell death in murine alveolar macrophages. Toxicol Appl Pharmacol 1996;139:135-143
169. Mangan DF, Wahl SM. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol 1991;147:3408-3412
170. Munn DH, Beall AC, Song D, Wrenn RW. Activation-induced apoptosis in human macrophages: Developmental regualtion of a novel cell death pathway by macrophage colony-stimulating factor and interferon-gamma. J Exp Med 1995;181:127-136
171. Kinscherf R, Claus R, Wagner M, et al. Apoptosis caused by oxidized LDL is manganese Superoxide dismutase and p53 dependent. FASEB J 1998;12:461-167
172. Quillet-Mary A, Jaffrezou JP, Mansat V, et al. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 1997;272:21388-21395
173. Meßmer UK, Reed JC, Brunes B. Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J Biol Chem 1996;271:20192-20197